These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3816491)

  • 21. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study.
    Gersony WM; Peckham GJ; Ellison RC; Miettinen OS; Nadas AS
    J Pediatr; 1983 Jun; 102(6):895-906. PubMed ID: 6343572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus.
    Keller RL; Clyman RI
    Pediatrics; 2003 Sep; 112(3 Pt 1):583-7. PubMed ID: 12949288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.
    Walters M
    BMJ; 1988 Sep; 297(6651):773-4. PubMed ID: 3142543
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indomethacin and furosemide in closure of ductus arteriosus].
    Vargas-Origel A; Cruz-Anguiano V; López-Montaño E
    Bol Med Hosp Infant Mex; 1986 Aug; 43(8):482-8. PubMed ID: 3755939
    [No Abstract]   [Full Text] [Related]  

  • 29. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome.
    Kääpä P; Lanning P; Koivisto M
    Acta Paediatr Scand; 1983 Mar; 72(2):179-84. PubMed ID: 6340412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic closure of patent ductus arteriosus in the premature infant.
    Friedman WF; Hirschklau MJ; Printz MP; Pitlick PT; Kirkpatrick SE
    N Engl J Med; 1976 Sep; 295(10):526-9. PubMed ID: 820994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ibuprofen as effective as indomethacin for patent ductus arteriosus.
    SoRelle R
    Circulation; 2000 Jul; 102(4):E9007-8. PubMed ID: 10908230
    [No Abstract]   [Full Text] [Related]  

  • 32. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
    Dollberg S; Lusky A; Reichman B
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymptomatic reopening of ductus arteriosus after successful closure by indomethacin in premature infants.
    Yen SL; Teng RJ; Ho MM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(5):379-84. PubMed ID: 8237357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double blind study of the effects of oral indomethacin in preterm infants with patent ductus arteriosus who failed medical management.
    Neu J; Ariagno RL; Johnson JD; Pitlick PT; Cohen RS; Beets CL; Sunshine P
    Pediatr Pharmacol (New York); 1981; 1(3):245-9. PubMed ID: 7346744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preterm infants with patent ductus arteriosus: treatment with an enteral preparation of indomethacin.
    So LY; Fok TF; Sung RY; Ho JK
    Ann Trop Paediatr; 1992; 12(4):403-8. PubMed ID: 1283670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus.
    Rajadurai VS; Yu VY
    J Paediatr Child Health; 1991 Dec; 27(6):370-5. PubMed ID: 1756081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of prolonged low-dose versus conventional-dose indomethacin for treating patent ductus arteriosus in very low birth weight infants.
    Lee J; Rajadurai VS; Tan KW; Wong KY; Wong EH; Leong JY
    Pediatrics; 2003 Aug; 112(2):345-50. PubMed ID: 12897285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation.
    Stefano JL; Abbasi S; Pearlman SA; Spear ML; Esterly KL; Bhutani VK
    Am Rev Respir Dis; 1991 Feb; 143(2):236-9. PubMed ID: 1990934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
    Andriessen P; Struis NC; Niemarkt H; Oetomo SB; Tanke RB; Van Overmeire B
    Acta Paediatr; 2009 May; 98(5):797-803. PubMed ID: 19187396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.